Knight Therapeutics Inc. ( GUD.TO) - Key Metrics
GUD.TO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | CA$1.34 | CA$0.09 | CA$0.35 | CA$0.34 |
| 2025Q3 | CA$1.22 | -CA$0.04 | CA$0.11 | CA$0.10 |
| 2025Q2 | CA$1.08 | -CA$0.13 | CA$0.20 | -CA$0.05 |
| 2025Q1 | CA$0.88 | CA$0.02 | CA$0.04 | CA$0 |
GUD.TO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 16.94 |
| 2025Q3 | ? | -38.64 |
| 2025Q2 | ? | -11.50 |
| 2025Q1 | ? | 70.11 |
GUD.TO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 5.09% | ? |
| 2025Q4 | 5.63% | ? |
| 2025Q3 | 1.73% | ? |
| 2025Q2 | -0.84% | ? |
| 2025Q1 | -0.01% | ? |
GUD.TO
Price: CA$8.46
52 week price:
Earnings Per Share: 0.06 CAD
P/E Ratio: 144.33
Exchange: TOR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 850.9 million